ArticleOncology letters2021

Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma.

Maja Sremac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.